Nathan is the Director of CMC Cell Therapy at TriArm Therapeutics, bringing extensive experience from roles at Bayer and Allogene Therapeutics. He specializes in developing manufacturing processes for allogeneic CAR-T cell therapies. He holds a Ph. D. from Iowa State University and an MBA from the University of Michigans Ross School of Business.
Outside of his direct scientific contributions, Nathan has a demonstrated passion for education, having earned multiple Teaching Excellence Awards during his graduate studies. This suggests a strong aptitude for mentorship and developing talent, complementing his technical and strategic leadership skills.
He once led a project that increased monoclonal antibody production by 250% and process robustness by 300%.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.